Topic: Private Equity

Subject: Medical Device for Point of Care COVID-19 Testing
Steve McMaster
Member: 2020
Submitted on 08-21-20 1:49 pm

Good morning everyone,

I am seeking advice for a startup that I'm advising. The company has developed a saliva testing device with a 5-minute turnaround for COVID detection, with greater than 90% accuracy. This device also detects real-time THC levels in a patient's blood. It's an incredible piece of technology, and its multi-use functionality holds true to its original thesis.

The company has several LOI's for large purchase volumes, and is soon concluding its clinical trials.

What is the typical multiple, or other preferred methods, for valuing a pre-revenue company in the medical device space?

Thank you,
Steve McMaster

 No replies